tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Next Science Limited Announces Successful Resolution at General Meeting

Story Highlights
  • Next Science Limited passed a resolution at its General Meeting by the required majority.
  • The resolution’s success may impact Next Science’s operations and industry position.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Next Science Limited Announces Successful Resolution at General Meeting

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

The latest announcement is out from Next Science Ltd ( (AU:NXS) ).

Next Science Limited announced the results of its General Meeting, where the resolution proposed was passed by the required majority through a poll. This outcome aligns with ASX Listing Rule 3.13.2 and section 251AA(2) of the Corporations Act 2001. The successful passing of the resolution is a significant step for the company, potentially impacting its operational strategies and strengthening its position in the medical technology industry.

The most recent analyst rating on (AU:NXS) stock is a Buy with a A$0.40 price target. To see the full list of analyst forecasts on Next Science Ltd stock, see the AU:NXS Stock Forecast page.

More about Next Science Ltd

Next Science is a medical technology company based in Sydney, Australia, with a research and development center in Florida, USA. Founded in 2012, the company focuses on developing and commercializing its proprietary XBIO™ technology, which effectively reduces biofilm-based infections in human health. The technology is unique, non-toxic, and has proven efficacy in eradicating both biofilm-based and free-floating bacteria. Next Science owns all patent-protected intellectual property related to XBIO™.

Average Trading Volume: 558,373

Technical Sentiment Signal: Sell

Current Market Cap: A$42.43M

See more data about NXS stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1